Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cohn

Showing results (501-510 of 612) with videos related to

Pageof 62
Sort By:
Oncogene|May 29, 1999
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cellsM Haber, S B Bordow, J Gilbert, et al.
Pediatric Blood & Cancer|November 28, 2018
The challenge of defining "ultra-high-risk" neuroblastomaDaniel A Morgenstern, Rochelle Bagatell, Susan L Cohn, et al.
The American Journal of Surgical Pathology|March 19, 2021
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology GroupAsuka Kawano, Florette K Hazard, Bill Chiu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2013
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology groupGregory A Yanik, Marguerite T Parisi, Barry L Shulkin, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidinesHeinz-Josef Lenz, Eric Van Cutsem, Shirin Khambata-Ford, et al.
The Journal of Infectious Diseases|September 4, 2010
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected menTimothy Wilkin, Jeannette Y Lee, Shelly Y Lensing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2020
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG ProjectElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|December 25, 2007
Prevalence of intestinal microsporidiosis in human immunodeficiency virus-infected patients with diarrhea in major United States citiesMark S Dworkin, Susan E Buskin, Arthur J Davidson, et al.
Histopathology|February 24, 2025
Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR)Jason A Jarzembowski, Fleur Webster, Klaus Beiske, et al.
Pageof 62

Showing results (501-510 of 612) with videos related to

Sort By:
Pageof 62
Oncogene|May 29, 1999
Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cellsM Haber, S B Bordow, J Gilbert, et al.
Pediatric Blood & Cancer|November 28, 2018
The challenge of defining "ultra-high-risk" neuroblastomaDaniel A Morgenstern, Rochelle Bagatell, Susan L Cohn, et al.
The American Journal of Surgical Pathology|March 19, 2021
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology GroupAsuka Kawano, Florette K Hazard, Bill Chiu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 27, 2013
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology groupGregory A Yanik, Marguerite T Parisi, Barry L Shulkin, et al.
British Journal of Cancer|April 30, 2009
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeP F Ambros, I M Ambros, G M Brodeur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidinesHeinz-Josef Lenz, Eric Van Cutsem, Shirin Khambata-Ford, et al.
The Journal of Infectious Diseases|September 4, 2010
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected menTimothy Wilkin, Jeannette Y Lee, Shelly Y Lensing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2020
Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG ProjectElizabeth Sokol, Ami V Desai, Mark A Applebaum, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|December 25, 2007
Prevalence of intestinal microsporidiosis in human immunodeficiency virus-infected patients with diarrhea in major United States citiesMark S Dworkin, Susan E Buskin, Arthur J Davidson, et al.
Histopathology|February 24, 2025
Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR)Jason A Jarzembowski, Fleur Webster, Klaus Beiske, et al.
Pageof 62